GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Redwood Pharma AB (OSTO:REDW) » Definitions » NonCurrent Deferred Liabilities

Redwood Pharma AB (OSTO:REDW) NonCurrent Deferred Liabilities : kr0.00 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Redwood Pharma AB NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Redwood Pharma AB's non-current deferred liabilities for the quarter that ended in Mar. 2024 was kr0.00 Mil.

Redwood Pharma AB NonCurrent Deferred Liabilities Historical Data

The historical data trend for Redwood Pharma AB's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redwood Pharma AB NonCurrent Deferred Liabilities Chart

Redwood Pharma AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial - - - - -

Redwood Pharma AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Redwood Pharma AB NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Redwood Pharma AB's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Redwood Pharma AB (OSTO:REDW) Business Description

Industry
Traded in Other Exchanges
Address
Ringvagen 100E, 9th Floor, Stockholm, SWE, 118 60
Redwood Pharma AB is engaged in developing new ophthalmic pharmaceutical therapies for unmet market needs. Its development product is a new therapy to treat chronic Dry Eye Disease (DED) in post-menopausal women.

Redwood Pharma AB (OSTO:REDW) Headlines

No Headlines